Abstract
Pulmonary diseases impose an immense burden on global health. Asthma,
cystic and idiopathic pulmonary fibrosis, pulmonary hypertension, lung cancer, and
chronic obstructive pulmonary diseases (COPD) are among the diseases that require
efficient pulmonary drug delivery. Targeted-drug delivery refers to the delivery of a drug
or a therapeutic agent to a certain tissue or organ; this can be achieved through pulmonary
drug delivery (PDD) with nanomaterials. Nanomaterials are made from polymers,
ceramics, metals, and biological materials into different sizes and structures.
Nanomaterials for PDD entail nanoparticles of therapeutic ingredients, including herbalbased drugs and nanocarriers of the therapeutic bioactive substance. These types of
materials used in managing pulmonary diseases are discussed in this chapter.
Keywords: Nanocarrier, Nanomaterial, Nanoparticle, Pulmonary diseases, Pulmonary drug delivery.
Related Journals
Current Drug Delivery
Current Bioactive Compounds
Current Drug Safety
Reviews on Recent Clinical Trials
Drug Delivery Letters
Recent Advances in Drug Delivery and Formulation
Recent Advances in Anti-Infective Drug Discovery
Drug Metabolism and Bioanalysis Letters
Applied Drug Research, Clinical Trials and Regulatory Affairs
Recent Patents on Drug Delivery & Formulation
Related Books
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems
Angiogenesis & Therapeutic Targets In Cancer
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Biopolymers In Drug Delivery: Recent Advances and Challenges
Chemoinformatics: Directions Toward Combating Neglected Diseases
Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms